WESPAC Advisors SoCal LLC Increases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

WESPAC Advisors SoCal LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 20,474 shares of the healthcare conglomerate’s stock after acquiring an additional 182 shares during the quarter. UnitedHealth Group accounts for approximately 2.6% of WESPAC Advisors SoCal LLC’s holdings, making the stock its 12th biggest holding. WESPAC Advisors SoCal LLC’s holdings in UnitedHealth Group were worth $8,055,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. Anfield Capital Management LLC bought a new position in shares of UnitedHealth Group in the second quarter worth approximately $26,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group in the second quarter valued at $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new stake in UnitedHealth Group in the second quarter valued at $28,000. Activest Wealth Management bought a new stake in UnitedHealth Group in the second quarter valued at $29,000. Finally, Ten Capital Wealth Advisors LLC boosted its holdings in UnitedHealth Group by 111.6% in the second quarter. Ten Capital Wealth Advisors LLC now owns 91 shares of the healthcare conglomerate’s stock valued at $36,000 after acquiring an additional 48 shares in the last quarter. 86.20% of the stock is currently owned by hedge funds and other institutional investors.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 75,000 shares of the company’s stock in a transaction on Monday, October 25th. The stock was sold at an average price of $448.72, for a total value of $33,654,000.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the stock in a transaction on Tuesday, November 23rd. The stock was sold at an average price of $444.70, for a total value of $1,111,750.00. The disclosure for this sale can be found here. Insiders sold a total of 82,500 shares of company stock valued at $36,855,125 over the last 90 days. 0.55% of the stock is currently owned by corporate insiders.

Several analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $421.00 to $477.00 and gave the company a “buy” rating in a report on Tuesday, November 16th. Mizuho raised their price objective on UnitedHealth Group from $455.00 to $500.00 and gave the company a “buy” rating in a research report on Wednesday, November 10th. Evercore ISI raised their price objective on UnitedHealth Group from $360.00 to $480.00 and gave the company an “outperform” rating in a research report on Friday, October 15th. Oppenheimer raised their price objective on UnitedHealth Group from $465.00 to $475.00 and gave the company an “outperform” rating in a research report on Friday, October 15th. Finally, Credit Suisse Group lifted their price target on UnitedHealth Group from $462.00 to $495.00 and gave the stock an “outperform” rating in a research report on Friday, October 15th. One equities research analyst has rated the stock with a hold rating, twenty-one have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $477.35.

Shares of NYSE:UNH traded up $3.03 during mid-day trading on Thursday, reaching $450.16. 2,248,836 shares of the company traded hands, compared to its average volume of 2,940,181. The company’s 50 day moving average price is $430.47 and its 200-day moving average price is $418.01. The firm has a market cap of $423.98 billion, a PE ratio of 27.93, a PEG ratio of 1.75 and a beta of 0.85. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.77 and a quick ratio of 0.77. UnitedHealth Group Incorporated has a 52 week low of $320.35 and a 52 week high of $466.00.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $4.41 by $0.11. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. The company had revenue of $72.34 billion during the quarter, compared to the consensus estimate of $71.24 billion. During the same period in the previous year, the company posted $3.51 EPS. The firm’s revenue was up 11.1% on a year-over-year basis. On average, research analysts predict that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 14th. Shareholders of record on Monday, December 6th will be paid a $1.45 dividend. The ex-dividend date of this dividend is Friday, December 3rd. This represents a $5.80 annualized dividend and a yield of 1.29%. UnitedHealth Group’s payout ratio is 35.98%.

UnitedHealth Group Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Recommended Story: Net Income

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.